ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TAK Takeda Pharmaceutical Company Ltd

13.022
-0.048 (-0.37%)
Last Updated: 12:44:38
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Takeda Pharmaceutical Company Ltd TAK NYSE Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.048 -0.37% 13.022 12:44:38
Open Price Low Price High Price Close Price Prev Close
13.08 13.005 13.08 13.07
more quote information »

Recent News

Date Time Source Heading
4/26/202408:30BWTakeda Receives Positive CHMP Opinion for Fruquintinib in..
4/23/202407:00PRNUSNeurocrine Biosciences Reports Positive Phase 2 Data for..
4/22/202404:10PRNUSTakeda, Astellas and Sumitomo Mitsui Banking Announce Master..
4/18/202419:00BWU.S. FDA Approves Subcutaneous Administration of Takeda’s..
4/08/202408:00BWTakeda Announces New U.S. Corporate Social Responsibility..
3/27/202408:56PRNUSEmpathy in Action: Takeda's Global Initiative Brings IBD..
3/27/202408:53PRNUSEmpathy in Action: Takeda's Global Initiative Brings IBD..
3/27/202401:01BWTakeda gibt Kandidaten für den Vorstand bei der kommenden..
3/26/202419:07BW武田薬品工業: 第148回定時株主総会に提案する取締役候補者について
3/26/202408:00BWTakeda Announces Approval of ADZYNMA® Intravenous Injection..
3/21/202409:39BW武田薬品、Ph+..
3/21/202403:33BWTakeda meldet sNDA-Zulassung von ICLUSIG® (Ponatinib) durch..
3/20/202415:18BWTakeda annonce l'approbation par la FDA des États-Unis d'une..
3/19/202412:20BWTakeda Announces U.S. FDA Approval of Supplemental New Drug..
3/19/202406:30GLOBECENTOGENE Extends Strategic Partnership With Takeda to..
3/13/202408:00BWTakeda Announces Positive Topline Results from Phase 2 Study..
2/28/202407:03BW武田薬品とBiological E. Limited、デング熱流行地域におけるワクチンへのアクセス促進で協力
2/27/202417:26BWTakeda et Biological E. Limited s’associent pour accélérer..
2/27/202407:38BWTakeda und Biological E. Limited arbeiten zusammen, um den..
2/26/202423:30BWTakeda and Biological E. Limited Collaborate to Accelerate..
2/26/202407:00PRNCAChampioning Rare Voices on Rare Disease Day
2/12/202408:00BWFDA Approves Takeda’s EOHILIA (budesonide oral suspension),..
2/08/202418:00BWTakeda Intends to Rapidly Initiate the First Global Phase 3..
2/01/202416:23BWTakeda gibt Nachfolger für die Position des Chief Financial..
2/01/202416:18BWTakeda annonce la succession de son directeur financier
2/01/202409:59BWTakeda gibt Ergebnisse für das dritte Quartal des..
2/01/202406:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/01/202406:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/01/202401:54BWTakeda Announces Chief Financial Officer Succession
2/01/202401:02BWTakeda Announces Third-Quarter FY2023 Results; On-Track..
1/30/202411:00BW武田薬品、慢性炎症性脱髄性多発根神経炎(CIDP)に対する維持療法としてのHYQVIA®について、欧州委員会から承認を獲得
1/30/202408:04BWTakeda-Arzneimittel HYQVIA ® von der Europäischen Kommission..
1/29/202413:55BWLe HYQVIA® de Takeda approuvé par la Commission européenne..
1/29/202411:10BWTakeda’s GAMMAGARD LIQUID® Approved by U.S. FDA for Adults..
1/29/202402:00BWTakeda’s HYQVIA® Approved by European Commission as..
1/25/202417:00PRNUSCognizant Helping to Modernize Infrastructure and..
1/25/202406:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202406:11EDGAR2Form SC 13D/A - General statement of acquisition of..
1/19/202406:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/18/202413:56BWTakeda est nommée Top Employer mondial pour la septième..
1/18/202413:45BW武田薬品工業、7年連続でトップ・エンプロイヤーに認定
1/18/202413:22BWTakeda im siebten Jahr in Folge international als Top..
1/18/202407:00BWTakeda Named Global Top Employer for Seventh Consecutive..
1/16/202408:00BWU.S. FDA Approves Takeda’s HYQVIA® as Maintenance Therapy in..
1/16/202406:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/21/202316:00BWTakeda Announces China NMPA Approval of LIVTENCITY®..
12/20/202307:01PRNCATakeda Enters Into Two-Year Contract with Canadian Blood..
12/16/202311:36BWTakeda obtient l’avis favorable du CHMP pour HYQVIA® en tant..
12/16/202310:47BWTakeda erhält positive CHMP-Stellungnahme für HYQVIA® als..
12/15/202308:16BWTakeda Receives Positive CHMP Opinion for HYQVIA® as..

Your Recent History

Delayed Upgrade Clock